Rare diseases
Investigational molecules
Locations
Back to Spain71 clinical trials in Sant Cugat Del Valles, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Phase 1/2 Study of ter-2013-01, imlunestrant, and fulvestrant in patients with solid tumors with AKT/PI3K/PTEN pathway alterations
SpainEfficacy and safety of ABP 938 compared with aflibercept in participants with neovascular age‑related macular degeneration
SpainEvaluation of zongertinib, fulvestrant and goserelin acetate in patients with HR‑positive HER2‑negative advanced breast cancer
SpainA Phase 2/3 Study of intravitreal mk-8748 versus aflibercept in adults with neovascular age‑related macular degeneration
SpainSpainFWY003 in Geographic Atrophy Secondary to Age-Related Macular Degeneration in Patients
SpainA study to evaluate the effectiveness and safety of efaglomograstim alfa in patients with low blood platelet counts caused by chemotherapy
SpainA study to evaluate the safety and effectiveness of NIO752 in patients with progressive supranuclear palsy
SpainStudy of elacestrant and ribociclib compared to standard treatment for patients with high-risk ER+/HER2- early breast cancer
SpainA study comparing prasinezumab with placebo for people with early-stage Parkinson's disease
SpainA Study Comparing RLY-2608 and Fulvestrant with Capivasertib and Fulvestrant for Patients with PIK3CA-Mutant Hormone Receptor Positive, HER2-Negative Advanced Breast Cancer
SpainStudy of Semaglutide on Embryo Quality in Overweight and Obese Women Undergoing In Vitro Fertilization for Infertility
SpainThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on Parkinson's Disease treatments, including multiple trials evaluating new therapeutic approaches. Studies are investigating novel compounds like tavapadon and BIIB122 for improved symptom management.
Innovative trials targeting Age-Related Macular Degeneration and its complications, particularly Geographic Atrophy. Research includes both intravitreal treatments and systemic approaches to manage disease progression.
Comprehensive research in breast cancer treatments, particularly focusing on HER2-positive and hormone receptor-positive variants. Studies evaluate new targeted therapies and combination treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
